VIDEO: Research on geographic atrophy should focus 'everywhere'

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

I think the answer to where research should be focused is everywhere. You know, I think this is kind of a wonderful space. It’s a very interesting space. And the question is, you know, we’re not stopping geographic atrophy. And that’s really important to understand that even though you’re treating patients on a monthly or every other month basis, there’s progression of the geographic atrophy. So that begs the clinical question, should we be treating at an earlier stage in kinda, some of those risk factors that we had discussed about progressing from intermediate to advanced AMD, should we treat earlier? But then of course, this comes at the cost of considerable dollars to the American health care system. And so I think we need to start to understand the value propositions in some economic studies to help us understand who we should be treating and at what level. So I think there’s so many different ways from the sort of translational side to the economic side that really need to be better fleshed out over the next couple of years.